Please login to the form below

Not currently logged in
Email:
Password:

canakinumab

This page shows the latest canakinumab news and features for those working in and with pharma, biotech and healthcare.

Alcon's return to growth gives Novartis 'options', says CEO

Alcon's return to growth gives Novartis 'options', says CEO

A string of positive pipeline news - including a positive FDA advisory committee meeting for CAR-T cancer immunotherapy CTL019 and encouraging data on ophthalmic drug brolucizumab and ACZ885 (canakinumab) in heart

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics